КАМНИ В ПОЧКАХ.
##article.abstract##
Камни в почках являются распространенным заболеванием: ежегодная заболеваемость составляет восемь случаев на 1000 взрослых. В течение
При эпизоде почечной колики первоочередной задачей является исключение состояний, требующих немедленного направления к врачу.
отделение неотложной помощи, затем для облегчения боли, желательно нестероидным противовоспалительным препаратом.
Диагностическое обследование включает анализ мочи, посев мочи и визуализацию для подтверждения диагноза и
оценить состояния, требующие активного удаления камней, например, инфекцию мочевыводящих путей или камень размером более
10 мм. Консервативное лечение состоит из контроля боли, медикаментозной вытесняющей терапии альфа-препаратами.
блокатор и последующая визуализация в течение 14 дней для мониторинга положения камней и оценки гидронефроза. Бессимптомные камни в почках должны сопровождаться серийной визуализацией и удаляться в
в случае роста, симптомов, обструкции мочевыводящих путей, рецидивирующих инфекций или отсутствия доступа к медицинской помощи.
Все пациенты с камнями в почках должны быть обследованы на предмет риска рецидива камней с учетом анамнеза.
базовая лабораторная оценка и визуализация. Следует изменить образ жизни, например, увеличить потребление жидкости.
рекомендуется всем пациентам, при этом следует назначать тиазидные диуретики, аллопуринол или цитраты.
для пациентов с рецидивирующими кальциевыми камнями. Пациентов с высоким риском рецидива камней следует направлять
для дополнительной оценки метаболизма, которая может служить основой для индивидуальных профилактических мер.
##submission.citations##
1. Frassetto L, Kohlstadt I. Treatment and prevention of kidney stones: an update. Am Fam Physician. 2011;84(11):1234-1242.
2. Alatab S, Pourmand G, El Howairis Mel F, et al. National profiles of urinary calculi: a comparison between developing and developed worlds. Iran J Kidney Dis. 2016;10(2):51-61.
3. López M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010;25(1):49-59.
4. Türk C, Petřík A, Sarica K, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol. 2016;69(3):468-474.
5. Sharma AP, Filler G. Epidemiology of pediatric urolithiasis. Indian J Urol. 2010;26(4):516-522.
6. Gabrielsen JS, Laciak RJ, Frank EL, et al. Pediatric urinary stone composition in the United States. J Urol. 2012;187(6):2182-2187.
7. Alelign T, Petros B. Kidney stone disease: an update on current concepts. Adv Urol. 2018;2018:3068365.
8. Roudakova K, Monga M. The evolving epidemiology of stone disease. Indian J Urol. 2014;30(1):44-48.
9. Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018;33(11):1033-1047.
10. Wijarnpreecha K, Lou S, Panjawatanan P, et al. Nonalcoholic fatty liver disease and urolithiasis. A systematic review and meta-analysis. J Gastrointestin Liver Dis. 2018;27(4):427-432.
11. Pietrow PK, Karellas ME. Medical management of common urinary calculi. Am Fam Physician. 2006;74(1):86-94.
12. Wright PJ, English PJ, Hungin AP, Marsden SN. Managing acute renal colic across the primary-secondary care interface: a pathway of care based on evidence and consensus [published correction appears in BMJ. 2003;326(7379):18]. BMJ. 2002;325(7377):1408-1412.
13. Bultitude M, Rees J. Management of renal colic. BMJ. 2012;345:e5499.
14. Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316-324.
15. Afshar K, Jafari S, Marks AJ, Eftekhari A, MacNeily AE. Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-opioids for acute renal colic. Cochrane Database Syst Rev. ;2015(6):CD006027.
16. Holdgate A, Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic [published correction appears in BMJ. 2004;329(7473):1019]. BMJ. 2004;328(7453):1401.
17. Pathan SA, Mitra B, Cameron PA. A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal colic. Eur Urol. 2018;73(4):583-595.
18. Worster AS, Bhanich Supapol W. Fluids and diuretics for acute ureteric colic. Cochrane Database Syst Rev. ;2012(2):CD004926.
19. Smith-Bindman R, Aubin C, Bailitz J, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med. 2014;371(12):1100-1110.
20. Niemann T, Kollmann T, Bongartz G. Diagnostic performance of low-dose CT for the detection of urolithiasis: a meta-analysis. AJR Am J Roentgenol. 2008;191(2):396-401.
21. Rodger F, Roditi G, Aboumarzouk OM. Diagnostic accuracy of low and ultra-low dose CT for identification of urinary tract stones: a systematic review. Urol Int. 2018;100(4):375-385.
22. Fulgham PF, Assimos DG, Pearle MS, Preminger GM. Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. J Urol. 2013;189(4):1203-1213.
23. Tchey DU, Ha YS, Kim WT, Yun SJ, Lee SC, Kim WJ. Expectant management of ureter stones: outcome and clinical factors of spontaneous passage in a single institution's experience. Korean J Urol. 2011;52(12):847-851.
24. Ahmed AF, Gabr AH, Emara AA, Ali M, Abdel-Aziz AS, Alshahrani S. Factors predicting the spontaneous passage of a ureteric calculus of ≥ 10 mm. Arab J Urol. 2015;13(2):84-90.
25. Coll DM, Varanelli MJ, Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol. 2002;178(1):101-103.
26. Hollingsworth JM, Canales BK, Rogers MA, et al. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. BMJ. 2016;355:i6112.
27. Wang H, Man LB, Huang GL, Li GZ, Wang JW. Comparative efficacy of tamsulosin versus nifedipine for distal ureteral calculi: a meta-analysis. Drug Des Devel Ther. 2016;10:1257-1265.
28. Pickard R, Starr K, MacLennan G, et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet. 2015;386(9991):341-349.
29. Chua ME, Park JH, Castillo JC, Morales ML. Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. Urolithiasis. 2013;41(2):143-151.
30. Skolarikos A, Straub M, Knoll T, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015;67(4):750-763.
31. Daudon M, Frochot V, Bazin D, Jungers P. Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment. Drugs. 2018;78(2):163-201.
32. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014(1):CD007470.
33. Izzedine H, Lescure FX, Bonnet F. HIV medication-based urolithiasis. Clin Kidney J. 2014;7(2):121-126.
34. Kahwati LC, Weber RP, Pan H, et al. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319(15):1600-1612.
35. Streeper NM. Asymptomatic renal stones—to treat or not to treat. Curr Urol Rep. 2018;19(5):29.
36. Semins MJ, Matlaga BR. Management of urolithiasis in pregnancy. Int J Womens Health. 2013;5:599-604.
37. Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161(9):659-667.
38. Fink HA, Wilt TJ, Eidman KE, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians clinical guideline [published correction appears in Ann Intern Med. 2013;159(3):230-232]. Ann Intern Med. 2013;158(7):535-543.
39. Fink HA, Akornor JW, Garimella PS, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009;56(1):72-80.
40. Phillips R, Hanchanale VS, Myatt A, Somani B, Nabi G, Biyani CS. Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev. ;2015(10):CD010057.
41. Prezioso D, Strazzullo P, Lotti T, et al. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group [published correction appears in Arch Ital Urol Androl. 2016;88(1):76]. Arch Ital Urol Androl. 2015;87(2):105-120.
42. McDowell SE, Thomas SK, Coleman JJ, Aronson JK, Ferner RE. A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy [published correction appears in J R Soc Med. 2013;106(4):119]. J R Soc Med. 2013;106(3):87-95.
43. Goldfarb DS, Coe RL. Prevention of recurrent nephrolithiasis. Am Fam Physician. 1999;60(8):2269-2276.
44. Portis AJ, Sundaram CP. Diagnosis and initial management of kidney stones. Am Fam Physician. 2001;63(7):1329-1339.
